Kilimanjaro - Climb for Cancer Clinical Trials

Climbing MT. Kilimanjaro to Promote – and Fund – Cancer Clinical Trials

Charles Blanke, MD, the head of one of the country’s largest cancer clinical research consortiums will scale Mt. Kilimanjaro next February to raise awareness of the importance of clinical trials in developing better treatments for cancer patients and to help more patients enroll to studies, while at the same time raising money to help offset dwindling federal funding of such studies.

Dr. Blanke, who is now training for the Kilimanjaro climb, is a Professor of Medicine at the Knight Cancer Institute at Oregon Health & Science University and serves as chair of SWOG Cancer Research.

Supporters of the Kilimanjaro Climb for Cancer Clinical Trials campaign can take part by making a donation. Contributions are being taken in by SWOG’s non-profit arm, The Hope Foundation, and fully 98 percent of each donation will go directly to cancer research. Click the links below to watch a brief video to meet Dr. Blanke and learn more about the climb and the reasons behind it. Also click below to help spread the word by liking the campaign’s Facebook page and sharing it with others.

Additional resources
Read more: Kilimanjaro Press Release
Watch the video: swog.org/kilimanjaro
Make a donation: swog.org/kilimanjaro
Like the event on Facebook: facebook.com/ClimbforCancerClinicalTrials

Group Logos